Clinical trial and in vitro study investigating topical application of Zataria multiflora Boiss. and Matricaria chamomilla extracts for androgenetic alopecia
This study was intended to evaluate the hair growth activity of Zataria multiflora Boiss. (ZM) and Matricaria chamomilla (MC) for androgenetic alopecia following a six-month clinical trial. In vitro studies were conducted to measure the inhibitory effects of MC and ZM against 5α-reductase (5αR). In...
Main Authors: | Anoosheh Sharifan, Ashraf Hajhoseini, Mahdi Bakhtiari |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Cogent Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2331205X.2017.1421405 |
Similar Items
-
PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN
by: Riezky Januar Pramitha, et al.
Published: (2013-03-01) -
Early-onset androgenetic alopecia and endocrine disruptors
by: M. Guarrera, et al.
Published: (2011-01-01) -
Assessment of cardiovascular risk in patients with androgenetic alopecia using high-sensitivity C-reactive protein and lipoprotein a
by: Magdy A Ragab, et al.
Published: (2019-01-01) -
Evaluation of the relationship between androgenetic alopecia and demodex infestation
by: Zari Javidi, et al.
Published: (2008-01-01) -
Androgenetic alopecia - Current status
by: Thomas Jayakar
Published: (2005-01-01)